Transcatheter implantation of the biological Sapien Edwards valve in the pulmonary position – first experiences

Demkow, Marcin; Rużyłło, Witold; Biernacka, Elżbieta Katarzyna; Kowalski, Mirosław; Śpiewak, Mateusz; Olivecrona, Göran; Hoffmań, Piotr

doi:10.5114/pwki.2011.23162

Cited by 3 publications

(4 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The SAPIEN TM valve is available in sizes larger than the current Melody ® , and therefore may be offered to patients with larger right ventricular outflow tracts (RVOT). We have recently reported on a single case of a successful pulmonary Edwards SAPIEN ™ valve implantation in a patient after RVOT correction with a patch . Now, we report a successful percutaneous Edwards SAPIEN ™ valve implantation in the pulmonary position in nine patients with severe pulmonary regurgitation after previous surgical repair with a RVOT patch.…”

Section: Introductionmentioning

confidence: 90%

“…Interestingly, a case series of four such patients successfully treated with PPVI using the Melody ® valve (Medtronic, Minneapolis, MN) have recently been described . Furthermore, successful implantations of the Edwards SAPIEN ™ transcatheter heart valves, which are commonly used but in the aortic position, have recently been reported in pulmonary conduits . The SAPIEN TM valve is available in sizes larger than the current Melody ® , and therefore may be offered to patients with larger right ventricular outflow tracts (RVOT).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Percutaneous edwards SAPIEN^™ valve implantation for significant pulmonary regurgitation after previous surgical repair with a right ventricular outflow patch

Demkow

Rużyłło

Biernacka

et al. 2013

Cathet Cardio Intervent

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 90%

Section: Introductionmentioning

confidence: 99%

Percutaneous edwards SAPIEN^™ valve implantation for significant pulmonary regurgitation after previous surgical repair with a right ventricular outflow patch

Demkow

Rużyłło

Biernacka

et al. 2013

Cathet Cardio Intervent

Self Cite

View full text Add to dashboard Cite

show abstract

“…SAPIEN valves are bovine pericardial tissue valves that are hand sutured to stainless-steel radiopaque stents, available in sizes 23, 26, and 29 mm. Tey are used after CE certifcation in the pulmonary position and have been previously reported in adult patients [34][35][36][37][38]. Te delivery system is more complex and designed for aortic valve implantation, resulting in signifcant difculty when negotiating the RVOT because of the curves involved, especially in smaller hearts.…”

Section: Discussionmentioning

confidence: 99%

Staged Percutaneous Management of Pulmonary Atresia and Intact Interventricular Septum: Stretching the Limits

El-Saiedi

Attia

Hanna

et al. 2023

Journal of Interventional Cardiology

View full text Add to dashboard Cite

Aims. Pulmonary atresia with intact ventricular septum (PA/IVS) can be treated by catheter-based interventions and complemented by various surgical procedures. We aim to determine a long-term treatment strategy to enable patients to be surgery free, depending solely on percutaneous interventions. Methods and Results. We selected five patients from among a cohort of patients with PA/IVS treated at birth with radiofrequency perforation and dilatation of the pulmonary valve. Patients had reached a pulmonary valve annulus of 20 mm or larger on their biannual echocardiographic follow-up, with right ventricular dilatation. The findings, together with the right ventricular outflow tract and pulmonary arterial tree, were confirmed by multislice computerised tomography. Based on the angiographic size of the pulmonary valve annulus, all patients were successfully implanted with either Melody® or Edwards® pulmonary valves percutaneously, regardless of their small weights and ages. No complications were encountered. Conclusion. We managed to stretch the age and weight limitations for performing percutaneous pulmonary valve implantation (PPVI): interventions were attempted whenever a pulmonary annulus size of >20 mm was reached, which was rationalised by the prevention of progressive right ventricular outflow tract dilatation and accommodating valves between 24 and 26 mm, which is enough to sustain a normal pulmonary flow in adulthood.

show abstract

“…SAPIEN3, equipped with an outer pericardial skirt, is designed to minimize perivalvular leak. The valve, manually crimped with a specialized tool, is implanted using the Retroflex-3 or Novaflex delivery system (Edwards Lifesciences) consisting of a guiding catheter and a single-balloon catheter [19–22]. …”

Section: Percutaneous Pulmonary Valve Implantationmentioning

confidence: 99%

Percutaneous pulmonary valve implantation – state of the art and Polish experience

Biernacka¹,

Rużyłło²,

Demkow³

2017

pwki

Self Cite

View full text Add to dashboard Cite

Percutaneous pulmonary valve implantation (PPVI) is a relatively new method of treating patients with right ventricular outflow tract (RVOT) dysfunction after surgical repair of congenital heart disease. Since its introduction in 2000 by Bonhoeffer, more than ten thousand PPVI procedures have been performed worldwide. Indications for PPVI have been adapted from those accepted for surgical intervention. Two types of valves are being used: Melody Medtronic available in diameters 16 mm and 18 mm and the family of Edwards SAPIEN valves 23, 26 and 29. The procedure has been shown to be feasible and safe when performed in patients with full pulmonary conduit dysfunction and in selected cases of patched RVOT. The low complication rate and the reduced number of open-chest re-interventions over a patient’s lifetime are among the main advantages of the procedure. The most important problem responsible for late mortality and reinterventions is infective endocarditis. Size restrictions of the currently available valves limit deployment in the majority of patients with a wide RVOT. Newer devices are being developed to make these patients suitable for PPVI. A literature review, Polish experience and results of PPVI performed in 66 patients in the Institute of Cardiology in Warsaw are briefly reported.

show abstract

Transcatheter implantation of the biological Sapien Edwards valve in the pulmonary position – first experiences

Cited by 3 publications

References 9 publications

Percutaneous edwards SAPIEN^™ valve implantation for significant pulmonary regurgitation after previous surgical repair with a right ventricular outflow patch

Percutaneous edwards SAPIEN^™ valve implantation for significant pulmonary regurgitation after previous surgical repair with a right ventricular outflow patch

Staged Percutaneous Management of Pulmonary Atresia and Intact Interventricular Septum: Stretching the Limits

Percutaneous pulmonary valve implantation – state of the art and Polish experience

Contact Info

Product

Resources

About

Transcatheter implantation of the biological Sapien Edwards valve in the pulmonary position – first experiences

Cited by 3 publications

References 9 publications

Percutaneous edwards SAPIEN™ valve implantation for significant pulmonary regurgitation after previous surgical repair with a right ventricular outflow patch

Percutaneous edwards SAPIEN™ valve implantation for significant pulmonary regurgitation after previous surgical repair with a right ventricular outflow patch

Staged Percutaneous Management of Pulmonary Atresia and Intact Interventricular Septum: Stretching the Limits

Percutaneous pulmonary valve implantation – state of the art and Polish experience

Contact Info

Product

Resources

About

Percutaneous edwards SAPIEN^™ valve implantation for significant pulmonary regurgitation after previous surgical repair with a right ventricular outflow patch

Percutaneous edwards SAPIEN^™ valve implantation for significant pulmonary regurgitation after previous surgical repair with a right ventricular outflow patch